The Cato Institute says if FDA wont resolve its conflicting stance over off-label use and promotion, the courts should do so.
Vifor asks FDA to take specific steps to stay actions the agency took in a 2020 citizen petition response purporting to change the established names a...
Federal Register notice: FDA seeks consumer organizations interested in participating in the selection of voting and nonvoting consumer representative...
The Federal Circuit Court of Appeals says promotional materials developed by Teva were enough to induce infringement of a GSK carvedilol patent despit...
FDA warns Captains Cloth it is marketing unapproved, adulterated, and misbranded KN95 face masks.
Federal Register notice: FDA announces a 10/6 Patient Engagement Advisory Committee meeting that will discuss and make recommendations on medical devi...
An FDA complete response letter asks FibroGen to conduct additional roxadustat clinical studies before resubmitting its NDA.
FDA warns Vivera Pharmaceuticals it is marketing unapproved, adulterated, and misbranded Covid-19 tests.